Back to funds
View filing
5AM Venture Management, LLC
hedge fundUpdated 27 days agoManaged by 5Am Venture Management, Llc • Latest filing Q2 2026
Portfolio value
$287.9M
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
-7.2%
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $391M |
| Q2 2023 | $401.4M |
| Q3 2023 | $347.5M |
| Q4 2023 | $377M |
| Q1 2024 | $446.6M |
| Q2 2024 | $447.1M |
| Q3 2024 | $484M |
| Q4 2024 | $419.1M |
| Q1 2025 | $264.4M |
| Q2 2025 | $260.1M |
| Q3 2025 | $273M |
| Q4 2025 | $318.1M |
| Q1 2026 | $360.2M |
| Q2 2026 | $287.9M |
Top holdings
16 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | M MPLT MAPLIGHT THERAPEUTICS INC | $34M | 950.0K | 11.83% | — |
| 2 | T TYRA TYRA BIOSCIENCES INC | $32.9M | 1.03M | 11.42% | — |
| 3 | T TRDA ENTRADA THERAPEUTICS INC | $29.9M | 4.06M | 10.37% | — |
| 4 | P PHVS PHARVARIS N V | $27.6M | 797.6K | 9.58% | — |
| 5 | C CAMP CAMP4 THERAPEUTICS CORP | $25.6M | 5.87M | 8.91% | — |
| 6 | ? N/A ARTIVA BIOTHERAPEUTICS INC | $22.8M | 2.35M | 7.93% | — |
| 7 | T TECX TECTONIC THERAPEUTIC INC | $20.9M | 606.7K | 7.24% | — |
| 8 | ? N/A ZENTALIS PHARMACEUTICALS INC | $19.1M | 3.95M | 6.65% | — |
| 9 | C CLDX CELLDEX THERAPEUTICS INC NEW | $18.5M | 497.3K | 6.43% | — |
| 10 | ? N/A EYEPOINT INC | $15M | 1.05M | 5.22% | — |
| 11 | B BHVN BIOHAVEN LTD | $11M | 739.0K | 3.82% | — |
| 12 | ? N/A SURROZEN INC | $7M | 271.3K | 2.44% | — |
| 13 | S SKYE SKYE BIOSCIENCE INC | $6.7M | 9.68M | 2.33% | — |
| 14 | A ALXO ALX ONCOLOGY HLDGS INC | $6.3M | 3.06M | 2.20% | — |
| 15 | T TARA PROTARA THERAPEUTICS INC | $5.2M | 1.37M | 1.82% | — |
| 16 | S SLNCF SILENCE THERAPEUTICS PLC | $5.2M | 476.2K | 1.82% | — |